Corista
Corista provides DP3, a scanner-agnostic digital pathology image management and workflow platform, sold via enterprise subscriptions to academic medical centers, hospital systems, and pharmaceutical/biotech research organizations for clinical, research, and education use.
- Company typePrivate
- Founded2005
- HeadquartersConcord, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Corista does
Corista is a privately held digital pathology software company founded in 2005 and headquartered in Concord, Massachusetts. The company develops and sells DP3 (Digital Pathology Processing Platform), a scanner-agnostic image management platform that consolidates whole-slide images, gross images, and static pathology images into a unified case management and collaborative workflow suite. DP3 includes modules for clinical healthcare, life sciences research, education, analytics, conference/tumor board review, and reporting, all built on a proprietary middleware layer (the LIS Connector) that integrates with heterogeneous LIS, HIS, and EHR systems. The platform also features a patented Virtual Slide Stage ergonomic hardware device and is CE-marked under IVDR for diagnostic use in Europe and licensed by Health Canada, with 510(k) clearance in progress in the United States.
Corista sells DP3 through direct enterprise sales to academic medical centers, hospital systems, and pharmaceutical/biotech research organizations, supplemented by strategic channel partnerships with scanner and imaging vendors including Evident (an Olympus subsidiary), Pramana, AGFA HealthCare, and Indica Labs. Revenue is generated through enterprise software licensing and subscriptions, complemented by implementation and integration professional services. The company targets enterprise customers including Dartmouth-Hitchcock Medical Center, Mayo Clinic, Massachusetts General Hospital, and unnamed multinational pharmaceutical/biotechnology firms. Corista is founder-led, with Elizabeth Wingard as Founder and CEO, and remains structured as a Massachusetts LLC, having filed an SEC Form D in December 2025 for an exempt securities offering of approximately $20 million to support growth and general corporate purposes.
Corista firmographics
Firmographics- Name
- Corista
- Legal name
- Corista, LLC
- Website
- https://corista.com
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Corista provides DP3, a scanner-agnostic digital pathology image management and workflow platform, sold via enterprise subscriptions to academic medical centers, hospital systems, and pharmaceutical/biotech research organizations for clinical, research, and education use.
- Ownership category
- akta.pro rank
Corista industry classification
Industry- Product category
- Digital Pathology Software
- NAICS
- Computer Systems Design and Related Services (54151), Custom Computer Programming Services (541511)
- SIC
- Services-Prepackaged Software (7372), Services-Computer Integrated Systems Design (7373), Services-Computer Programming, Data Processing, Etc. (7370)
- akta.pro primary industry
- Anatomic Pathology LIS & Digital Pathology Workflow (HLACAMAB)
- akta.pro secondary industries
- Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity) (HLACABAM), Vendor Neutral Archive (VNA) & Enterprise Imaging Repositories (HLACALAC)
Keywords
Where Corista is headquartered
LocationHeadquarters
- HQ city
- Concord
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Corista business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Software Licenses and Subscriptions: DP3 is sold as a software platform to healthcare organizations and life sciences companies, likely through enterprise license or subscription arrangements. Pricing is not publicly disclosed and appears to be quote-based given the enterprise nature of sales.
- Professional Services and Implementation: Corista provides implementation and integration services for digital health systems, including deployment, configuration, and training as part of customer onboarding.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels7 records
Corista product offering
Product offeringCore offering
Corista develops and sells the DP3 (Digital Pathology Processing Platform), a scanner-agnostic image management software suite for pathology workflows. DP3 integrates whole-slide imaging, LIS/EHR connectivity, AI analytics, and real-time voice-enabled collaboration into a unified dashboard serving clinical, research, and education use cases at hospitals, medical centers, and life sciences companies. Corista also sells the patented Virtual Slide Stage (VSS) hardware device and provides implementation, integration, and training services.
Product overview
Corista offers the DP3 (Digital Pathology Processing Platform) as its core integrated digital pathology solution. DP3 is a comprehensive platform comprising multiple modules: Healthcare Module for clinical pathology workflows, Life Sciences Module for research applications, Research Module for project-based workflows, Education Module for teaching and training, Analytics Module for quantitative image analysis, Conference Module for multidisciplinary reviews, and Reports Module for QA insights. The platform includes a proprietary LIS Connector middleware for integration with laboratory and health information systems. Corista also offers the Virtual Slide Stage (VSS) hardware device for improved ergonomic digital slide viewing. All modules share the same image management foundation, supporting whole slide images, gross images, and static pathology images with voice collaboration and remote case review capabilities.
Differentiator
Problem solved
Functional benefit
Brands
- DP3: Digital Pathology Processing Platform - Corista's proprietary image management software platform for digital pathology workflows
Products and services
- DP3 (Digital Pathology Processing Platform) Integrated, scanner-agnostic digital pathology image management software that consolidates whole-slide images, gross images, static pathology images, and case metadata into a single dashboard for clinical, research, and education workflows at hospitals, medical centers, and life sciences organizations.
- Virtual Slide Stage (VSS) Patented desktop hardware interface device (about the size of a paperback book) that allows pathologists to view digital pathology slides using the same fine motor skills as traditional glass slide microscopy, easing adoption of digital workflows.
- LIS Connector Integration Engine
Quantifiable outcome
- Turnaround time reduced from up to 2 weeks to as little as 1 hour for inter-institutional case reviews (Corista white paper, 'Crossing the Digital Divide')
- +3 more outcomes
Companies that use Corista
Customer profileNamed customers4 records
Segments2 records
Ideal customer profiles3 records
Corista technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration7 records
AI capability4 records
Feature10 records
Corista partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered flagship, core and minor.
- PramanaflagshipPartnership combines Pramana's AI-enabled, high-throughput whole slide image scanning capabilities with Corista's DP3 platform to deliver fully automated, integrated digital pathology solutions for high-volume pathology laboratories. The collaboration builds a pathology-specific blueprint for clinical consult programs, global research networks, tissue archiving, and data lake assembly. Pramana is an AI-enabled health tech company headquartered in Cambridge, Mass., founded by nference, Inc.
- Evident (Olympus Corporation subsidiary)flagshipEvident, a wholly-owned subsidiary of Olympus Corporation (formerly the Scientific Solutions division), partnered with Corista to extend digital pathology capabilities to its global customer base. Evident chose to partner with Corista in response to customer needs for expanded digital pathology capabilities. Corista's DP3 is the digital pathology software platform of choice for Evident's clients seeking advanced clinical, research, and educational capabilities.
- Indica LabscoreIntegration between Corista's DP3 and Indica Labs' HALO quantitative image analytics platform provides pathologists instant access to deep tissue biomarker analysis directly within the DP3 workflow. The integration removes the need to build algorithms from scratch and enables archiving of results directly into DP3, with HALO's open API enabling scalable solutions.
- DolbeycoreCorista partnered with Dolbey for speech recognition and workflow automation, integrated with Xifin LIS to deliver a completely hands-free, automated pathology workflow within the DP3 platform.
- XifincoreCorista's LIS partner Xifin provides laboratory information system integration, enabling DP3 to connect with Xifin's LIS platform for fully automated, hands-free pathology workflow when combined with Dolbey speech recognition.
- AGFA HealthCarecoreCorista announced partnership with AGFA HealthCare to enhance digital pathology integration, enabling tighter interoperability between AGFA's enterprise imaging solutions and Corista's DP3 platform.
- VoicebookminorCorista partnered with Voicebook to transform pathology workflows through voice-enabled collaboration and documentation tools integrated into the DP3 platform.
- InteropKeyminorHealthcare Innovators InteropKey and Corista joined forces to capture the expanding value-based care market through interoperability-focused go-to-market activities.
- EVIDENT (Olympus)flagshipEVIDENT (Evident), a wholly-owned subsidiary of Olympus Corporation, announced an alliance with Corista to automate digital pathology workflows, delivering integrated digital pathology solutions to clients worldwide.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
Corista competitors and assessment
Company assessmentBroad incumbents
- Sectra: Sectra offers enterprise imaging solutions including a digital pathology module integrated with its PACS/VNA platform. It competes with Corista on multi-vendor, vendor-neutral pathology image management, particularly in European health systems.
- Hamamatsu Photonics (NanoZoomer): Hamamatsu provides NanoZoomer whole slide scanners and associated image management software. It is a broad incumbent in the digital pathology imaging space, with overlapping workflow tooling for clinical and research labs.
- Philips (Philips IntelliSite Pathology Solution): Philips offers IntelliSite Digital Pathology Solution, a fully integrated hardware-and-software platform competing directly with Corista's DP3 in clinical pathology workflows. As a global healthcare conglomerate, Philips is a broad incumbent with overlapping digital pathology capabilities.
- Leica Biosystems (Aperio): Leica Biosystems (a Danaher company) offers Aperio digital pathology scanning and image management solutions. It competes head-to-head with Corista in scanner-centric pathology workflows, particularly for research and clinical use.
- Roche (Ventana Digital Pathology): Roche's Ventana division offers integrated whole-slide imaging scanners and image management software for clinical pathology, directly competing with DP3. Roche is a broad incumbent leveraging its diagnostics franchise to bundle pathology workflow tools.
Emerging players
- Ibex Medical Analytics: Ibex offers AI-driven cancer diagnostics with a dedicated workflow platform (Galen) for pathology. It is an emerging player targeting the same clinical pathology use cases as Corista's DP3, with a focus on integrated AI rather than vendor-neutral orchestration.
- PathAI: PathAI develops AI-powered pathology diagnostics and operates its own AISight image management platform. It is an emerging player competing with Corista in the intersection of AI analytics and clinical workflow, particularly for biopharma and academic labs.
- Qritive: Qritive provides AI-powered pathology analysis integrated with workflow tools. It is an emerging player and a Corista partner (per DP3 integrations) competing in adjacent pathology AI use cases where Corista's AI-enabled modules are positioned.
Direct peers
- Pramana: Pramana (founded by nference) provides AI-enabled high-throughput whole slide scanning and digital pathology workflow tools. It is both a Corista integration partner and a directly comparable vendor competing in image management for high-volume pathology labs.
- Indica Labs: Indica Labs provides HALO quantitative image analysis software for pathology and is an active integration partner of Corista. Its HALO platform overlaps with DP3's Analytics Module for biomarker analysis, making it a directly comparable vendor in the digital pathology workflow stack.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
Corista social profiles
Digital presenceCorista compliance and trust
Trust signalCompliance6 records
Corista financial estimates
Financial estimateRevenue estimate
Valuation estimate
Corista leadership team
Management profileNumber of profiles
Profiles3 records
Corista funding detail
Funding detailFunding overview
Funding rounds2 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Corista M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Corista
What does Corista do?
Corista develops and sells the DP3 (Digital Pathology Processing Platform), a scanner-agnostic image management software suite for pathology workflows. DP3 integrates whole-slide imaging, LIS/EHR connectivity, AI analytics, and real-time voice-enabled collaboration into a unified dashboard serving clinical, research, and education use cases at hospitals, medical centers, and life sciences companies. Corista also sells the patented Virtual Slide Stage (VSS) hardware device and provides implementation, integration, and training services.
Is Corista a public or private company?
Corista is a private company. It is classified as venture growth investor backed and is currently operating.
When was Corista founded?
Corista was founded in 2005. It employs 11 to 50 people.
Where is Corista based?
Corista is headquartered in Concord, United States, in the North America region.
How does Corista make money?
Two revenue lines are on record. Software Licenses and Subscriptions are the primary driver. The others are professional Services and Implementation.
Who are Corista's main competitors?
Broad incumbents on record are Sectra, Hamamatsu Photonics (NanoZoomer), Philips (Philips IntelliSite Pathology Solution), Leica Biosystems (Aperio) and Roche (Ventana Digital Pathology). Emerging players are Ibex Medical Analytics, PathAI and Qritive. Direct peers are Pramana and Indica Labs.
Does Corista have an API?
No public API is recorded for Corista.
What industry is Corista in?
Corista's product category is Digital Pathology Software. Its primary akta.pro industry code is HLACAMAB, Anatomic Pathology LIS & Digital Pathology Workflow, with a secondary code of HLACABAM, Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity). Its NAICS code is 54151 and its SIC code is 7372.